{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:06:20Z","timestamp":1791864380722,"version":"4.3.4"},"publisher-location":"New York, NY","reference-count":81,"publisher":"Springer New York","isbn-type":[{"value":"9781461406495","type":"print"},{"value":"9781461406501","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-1-4614-0650-1_4","type":"book-chapter","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T10:43:17Z","timestamp":1315651397000},"page":"57-66","source":"Crossref","is-referenced-by-count":44,"title":["Blood Sphingolipids in Homeostasis and Pathobiology"],"prefix":"10.1007","author":[{"given":"Samar M.","family":"Hammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"6585","key":"4_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/381800a0","volume":"381","author":"O Cuvillier","year":"1996","unstructured":"Cuvillier O, Pirianov G, Kleuser B et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 381(6585):800\u2013803.","journal-title":"Nature"},{"issue":"5294","key":"4_CR2","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1126\/science.274.5294.1855","volume":"274","author":"YA Hannun","year":"1996","unstructured":"Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science 1996; 274(5294): 1855\u20131859.","journal-title":"Science"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3350465","volume":"335","author":"S Mathias","year":"1998","unstructured":"Mathias S, Pena LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J 1998; 335 (Pt 3):465\u2013480.","journal-title":"Biochem J"},{"issue":"12","key":"4_CR4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1096\/fasebj.10.12.8903509","volume":"10","author":"S Spiegel","year":"1996","unstructured":"Spiegel S, Merrill AH Jr.Sphingolipid metabolism and cell growth regulation. FASEB J 1996; 10(12):1388\u20131397.","journal-title":"FASEB J"},{"issue":"29","key":"4_CR5","doi-asserted-by":"publisher","first-page":"25843","DOI":"10.1074\/jbc.R200009200","volume":"277","author":"AH Merrill Jr","year":"2002","unstructured":"Merrill AH Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 2002; 277(29):25843\u201325846.","journal-title":"J Biol Chem"},{"issue":"4","key":"4_CR6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1042\/bst0251171","volume":"25","author":"YA Hannun","year":"1997","unstructured":"Hannun YA, Obeid LM. Ceramide and the eukaryotic stress response. Biochem Soc Trans 1997; 25(4):1171\u20131175.","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"4_CR7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/jn\/129.7.1239","volume":"129","author":"H Vesper","year":"1999","unstructured":"Vesper H, Schmelz EM, Nikolova-Karakashian MN et al. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 1999; 129(7):1239\u20131250.","journal-title":"J Nutr"},{"issue":"7\u20138","key":"4_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.nut.2007.04.014","volume":"23","author":"I Ichi","year":"2007","unstructured":"Ichi I, Nakahara K, Kiso K et al. Effect of dietary cholesterol and high fat on ceramide concentration in rat tissues. Nutrition 2007; 23(7\u20138):570\u2013574.","journal-title":"Nutrition"},{"issue":"2","key":"4_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0005-2760(95)00104-K","volume":"1258","author":"H Katsikas","year":"1995","unstructured":"Katsikas H, Wolf C. Blood sphingomyelins from two European countries. Biochim Biophys Acta 1995; 1258(2):95\u2013100.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"4_CR10","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/biot.200800322","volume":"4","author":"FB Ozbayraktar","year":"2009","unstructured":"Ozbayraktar FB, Ulgen KO. Molecular facets of sphingolipids: mediators of diseases. Biotechnol J 2009; 4(7):1028\u20131041.","journal-title":"Biotechnol J"},{"issue":"6","key":"4_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-2275(20)38884-2","volume":"8","author":"DE Vance","year":"1967","unstructured":"Vance DE, Sweeley CC. Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res 1967; 8(6):621\u2013630.","journal-title":"J Lipid Res"},{"issue":"3\u20134","key":"4_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.prostaglandins.2007.11.002","volume":"85","author":"SM Hammad","year":"2008","unstructured":"Hammad SM, Crellin HG, Wu BX et al. Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages. Prostaglandins Other Lipid Mediat 2008; 85(3\u20134):107\u2013114.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"6569","key":"4_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/380075a0","volume":"380","author":"M Verheij","year":"1996","unstructured":"Verheij M, Bose R, Lin XH et al. Requirement for ceramide-initiated SAPK\/JNK signalling in stress-induced apoptosis. Nature 1996; 380(6569):75\u201379.","journal-title":"Nature"},{"issue":"31","key":"4_CR14","doi-asserted-by":"publisher","first-page":"21533","DOI":"10.1074\/jbc.274.31.21533","volume":"274","author":"N Aug\u00e9","year":"1999","unstructured":"Aug\u00e9 N, Nikolova-Karakashian M, Carpentier S et al. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase and sphingosine kinase. J Biol Chem 1999; 274(31):21533\u201321538.","journal-title":"J Biol Chem"},{"issue":"5","key":"4_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0952-7915(02)00374-6","volume":"14","author":"V Brinkmann","year":"2002","unstructured":"Brinkmann V, Lynch KR. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 2002; 14(5):569\u2013575.","journal-title":"Curr Opin Immunol"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/978-1-60761-322-0_22","volume":"579","author":"J Bielawski","year":"2009","unstructured":"Bielawski J, Pierce JS, Snider J et al. Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods Mol Biol 2009; 579:443\u2013467.","journal-title":"Methods Mol Biol"},{"key":"4_CR17","doi-asserted-by":"crossref","unstructured":"Hammad SM, Pierce JS, Soodavar F et al. Blood sphingolipidomics in healthy humans: Impact of sample collection methodology. J Lipid Res 2010.","DOI":"10.1194\/jlr.D008532"},{"issue":"4","key":"4_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","volume":"26","author":"EJ Jeyarajah","year":"2006","unstructured":"Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006; 26(4):847\u2013870.","journal-title":"Clin Lab Med"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1042\/0264-6021:3520809","volume":"352","author":"N Murata","year":"2000","unstructured":"Murata N, Sato K, Kon J et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 2000; 352 Pt 3:809\u2013815.","journal-title":"Biochem J"},{"issue":"3","key":"4_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","volume":"50","author":"P Wiesner","year":"2009","unstructured":"Wiesner P, Leidl K, Boettcher A et al. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 2009; 50(3):574\u2013585.","journal-title":"J Lipid Res"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/0264-6021:3490385","volume":"349","author":"S Pyne","year":"2000","unstructured":"Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 2000; 349(Pt2):385\u2013402.","journal-title":"Biochem J"},{"issue":"1\u20134","key":"4_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0090-6980(01)00109-5","volume":"64","author":"T Hla","year":"2001","unstructured":"Hla T. Sphingosine 1-phosphate receptors. Prostaglandins 2001; 64(1\u20134):135\u2013142.","journal-title":"Prostaglandins"},{"issue":"36","key":"4_CR23","doi-asserted-by":"publisher","first-page":"25074","DOI":"10.1074\/jbc.M801214200","volume":"283","author":"KM Argraves","year":"2008","unstructured":"Argraves KM, Gazzolo PJ, Groh EM et al. High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J Biol Chem 2008; 283(36):25074\u201325081.","journal-title":"J Biol Chem"},{"issue":"1","key":"4_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1083\/jcb.130.1.193","volume":"130","author":"KE Bornfeldt","year":"1995","unstructured":"Bornfeldt KE, Graves LM, Raines EW et al. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol 1995; 130(1):193\u2013206.","journal-title":"J Cell Biol"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/0264-6021:3480071","volume":"348","author":"T Kimura","year":"2000","unstructured":"Kimura T, Watanabe T, Sato K et al. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J 2000; 348 Pt 1:71\u201376.","journal-title":"Biochem J"},{"issue":"3","key":"4_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0092-8674(00)81661-X","volume":"99","author":"MJ Lee","year":"1999","unstructured":"Lee MJ, Thangada S, Claffey KP etal. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999; 99(3):301\u2013312.","journal-title":"Cell"},{"issue":"8","key":"4_CR27","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1074\/jbc.272.8.5291","volume":"272","author":"Y Yatomi","year":"1997","unstructured":"Yatomi Y, Yamamura S, Ruan F et al. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J Biol Chem 1997; 272(8):5291\u20135297.","journal-title":"J Biol Chem"},{"issue":"8","key":"4_CR28","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1161\/ATVBAHA.107.145672","volume":"27","author":"A Kontush","year":"2007","unstructured":"Kontush A, Therond P, Zerrad A et al. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol 2007; 27(8):1843\u20131849.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"4_CR29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1160\/TH08-10-0675","volume":"101","author":"C Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez C, Gonz\u00e1lez-Diez M, Badimon L et al. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. Thromb Haemost 2009; 101(4):665\u2013673.","journal-title":"Thromb Haemost"},{"issue":"1","key":"4_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000315109","volume":"26","author":"S Lucke","year":"2010","unstructured":"Lucke S, Levkau B. Endothelial functions of sphingosine-1-phosphate. Cell Physiol Biochem 2010; 26(1):87\u201396.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"4_CR31","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1476-5381.2009.00281.x","volume":"158","author":"GF Nixon","year":"2009","unstructured":"Nixon GF. Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 2009; 158(4):982\u2013993.","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"4_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1388-1981(02)00147-6","volume":"1582","author":"F Okajima","year":"2002","unstructured":"Okajima F. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 2002; 1582(1\u20133): 132\u2013137.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0002-8703(03)00118-2","volume":"146","author":"DH Deutschman","year":"2003","unstructured":"Deutschman DH, Carstens JS, Klepper RL et al. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 2003; 146(1):62\u201368.","journal-title":"Am Heart J"},{"key":"4_CR34","doi-asserted-by":"crossref","unstructured":"Lee MH, Hammad SM, Semler AJ et al. HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes\u2014the role of sphingosine-1-phosphate. J Lipid Res 2010.","DOI":"10.1194\/jlr.M003988"},{"issue":"4A","key":"4_CR35","doi-asserted-by":"publisher","first-page":"42J","DOI":"10.1016\/S0002-9149(03)00615-5","volume":"92","author":"DJ Rader","year":"2003","unstructured":"Rader DJ. Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol 2003; 92(4A):42J\u201349J.","journal-title":"Am J Cardiol"},{"issue":"45","key":"4_CR36","doi-asserted-by":"publisher","first-page":"26910","DOI":"10.1074\/jbc.270.45.26910","volume":"270","author":"DL Sparks","year":"1995","unstructured":"Sparks DL, Davidson WS, Lund-Katz S et al. Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability. J Biol Chem 1995; 270(45):26910\u201326917.","journal-title":"J Biol Chem"},{"issue":"19","key":"4_CR37","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1021\/bi992902m","volume":"39","author":"LK Curtiss","year":"2000","unstructured":"Curtiss LK, Bonnet DJ, Rye KA. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Biochemistry 2000;39(19):5712\u20135721.","journal-title":"Biochemistry"},{"key":"4_CR38","doi-asserted-by":"crossref","unstructured":"Vedhachalam C, Chetty PS, Nickel M et al. Influence of apolipoprotein (APO) A-I structure on nascent high density lipoprotein (HDL) particle size distribution. J Biol Chem 2010.","DOI":"10.1074\/jbc.M110.126292"},{"issue":"4","key":"4_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MOL.0b013e32833b7756","volume":"21","author":"RM Krauss","year":"2010","unstructured":"Krauss RM. Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol 2010; 21(4): 305\u2013311.","journal-title":"Curr Opin Lipidol"},{"key":"4_CR40","doi-asserted-by":"crossref","unstructured":"Sattler KJ, Elbasan S, Keul P et al. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol 2010.","DOI":"10.1007\/s00395-010-0112-5"},{"issue":"7","key":"4_CR41","first-page":"1871","volume":"119","author":"E Camerer","year":"2009","unstructured":"Camerer E, Regard JB, Cornelissen I et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 2009; 119(7):1871\u20131879.","journal-title":"J Clin Invest"},{"issue":"5822","key":"4_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1139221","volume":"316","author":"R Pappu","year":"2007","unstructured":"Pappu R, Schwab SR, Cornelissen I et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007; 316(5822):295\u2013298.","journal-title":"Science"},{"issue":"6","key":"4_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","volume":"102","author":"K Venkataraman","year":"2008","unstructured":"Venkataraman K, Lee YM, Michaud J et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 2008; 102(6):669\u2013676.","journal-title":"Circ Res"},{"issue":"2","key":"4_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1046\/j.1365-2141.1999.01697.x","volume":"107","author":"L Yang","year":"1999","unstructured":"Yang L, Yatomi Y, Miura Y et al. Metabolism and functional effects of sphingolipids in blood cells. Br J Haematol 1999; 107(2):282\u2013293.","journal-title":"Br J Haematol"},{"issue":"5","key":"4_CR45","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/oxfordjournals.jbchem.a021681","volume":"121","author":"Y Yatomi","year":"1997","unstructured":"Yatomi Y, Igarashi Y, Yang L et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 1997; 121(5):969\u2013973.","journal-title":"J Biochem"},{"issue":"5","key":"4_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","volume":"4","author":"S Spiegel","year":"2003","unstructured":"Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003;4(5):397\u2013407.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1\u20132","key":"4_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.prostaglandins.2005.12.004","volume":"79","author":"SM Hammad","year":"2006","unstructured":"Hammad SM, Taha TA, Nareika A et al. Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells. Prostaglandins Other Lipid Mediat 2006; 79(1\u20132): 126\u2013140.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"4_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.chemphyslip.2008.06.003","volume":"155","author":"LS Kumpula","year":"2008","unstructured":"Kumpula LS, Kumpula JM, Taskinen MR et al. Reconsideration of hydrophobic lipid distributions in lipoprotein particles. Chem Phys Lipids 2008; 155(1):57\u201362.","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"4_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1050-1738(01)00143-8","volume":"12","author":"PK Kinnunen","year":"2002","unstructured":"Kinnunen PK, Holopainen JM. Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide and apoptosis? Trends Cardiovasc Med 2002; 12(1):37\u201342.","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"4_CR50","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1529\/biophysj.105.069849","volume":"90","author":"M Heikela","year":"2006","unstructured":"Heikela M, Vattulainen I, Hyvonen MT. Atomistic simulation studies of cholesteryl oleates: model for the core of lipoprotein particles. Biophys J 2006; 90(7):2247\u20132257.","journal-title":"Biophys J"},{"issue":"13","key":"4_CR51","doi-asserted-by":"publisher","first-page":"i519","DOI":"10.1093\/bioinformatics\/btm181","volume":"23","author":"M Sysiaho","year":"2007","unstructured":"Sysi-aho M, Vehtari A, Velagapudi VR et al. Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles. Bioinformatics 2007; 23(13):i519\u2013i528.","journal-title":"Bioinformatics"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","volume":"50","author":"N Bartke","year":"2009","unstructured":"Bartke N, Hannun YA. Bioactive sphingolipids: metabolism and function. J Lipid Res 2009; 50 Suppl: S91\u2013S96.","journal-title":"J Lipid Res"},{"issue":"1","key":"4_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tem.2008.09.004","volume":"20","author":"LA Cowart","year":"2009","unstructured":"Cowart LA. Sphingolipids: players in the pathology of metabolic disease. Trends Endocrinol Metab 2009; 20(1):34\u201342.","journal-title":"Trends Endocrinol Metab"},{"issue":"17","key":"4_CR54","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","volume":"64","author":"S Lahiri","year":"2007","unstructured":"Lahiri S, Futerman AH. The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci 2007; 64(17):2270\u20132284.","journal-title":"Cell Mol Life Sci"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1042\/0264-6021:3550189","volume":"355","author":"K Liliom","year":"2001","unstructured":"Liliom K, Sun G, B\u00fcnemann M et al. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem J 2001;355(Pt 1):189\u2013197.","journal-title":"Biochem J"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1194\/jlr.R800073-JLR200","volume":"50","author":"AJ Merrill","year":"2009","unstructured":"Merrill AH Jr, Stokes TH, Momin A et al. Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J Lipid Res 2009; 50 Suppl: S97\u2013S102.","journal-title":"J Lipid Res"},{"issue":"2","key":"4_CR57","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrm2335","volume":"9","author":"MP Wymann","year":"2008","unstructured":"Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008; 9(2):162\u2013176.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"4_CR58","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.bbamem.2006.09.026","volume":"1768","author":"D Meyer zu Heringdorf","year":"2007","unstructured":"Meyer zu Heringdorf D, Jakobs KH. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 2007; 1768(4):923\u2013940.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"4_CR59","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/08916930701356911","volume":"40","author":"RB Mueller","year":"2007","unstructured":"Mueller RB, Sheriff A, Gaipl US et al. Attraction of phagocytes by apoptotic cells is mediated by lysophosphatidylcholine. Autoimmunity 2007; 40(4):342\u2013344.","journal-title":"Autoimmunity"},{"issue":"2","key":"4_CR60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cellsig.2006.07.001","volume":"19","author":"M Tani","year":"2007","unstructured":"Tani M, Ito M, Igarashi Y. Ceramide\/sphingosine\/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell Signal 2007; 19(2):229\u2013237.","journal-title":"Cell Signal"},{"issue":"29","key":"4_CR61","doi-asserted-by":"publisher","first-page":"25859","DOI":"10.1074\/jbc.R200001200","volume":"277","author":"T Kolter","year":"2002","unstructured":"Kolter T, Proia RL, Sandhoff K. Combinatorial ganglioside biosynthesis. J Biol Chem 2002; 277(29): 25859\u201325862.","journal-title":"J Biol Chem"},{"issue":"29","key":"4_CR62","doi-asserted-by":"publisher","first-page":"25847","DOI":"10.1074\/jbc.R200008200","volume":"277","author":"YA Hannun","year":"2002","unstructured":"Hannun YA, Obeid LM. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 2002; 277(29):25847\u201325850.","journal-title":"J Biol Chem"},{"issue":"2","key":"4_CR63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9(2): 139\u2013150.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"4_CR64","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0","volume":"31","author":"A Pfeiffer","year":"2001","unstructured":"Pfeiffer A, B\u00f6ttcher A, Ors\u00f3 E et al. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol 2001; 31(11):3153\u20133164.","journal-title":"Eur J Immunol"},{"issue":"1","key":"4_CR65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1570-0232(02)00177-0","volume":"776","author":"T Fujiwaki","year":"2002","unstructured":"Fujiwaki T, Yamaguchi S, Tasaka M et al. Application of delayed extraction-matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in pericardial fluid, peritoneal fluid and serum from Gaucher disease patients. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 776(1):115\u2013123.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"4_CR66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jchromb.2005.12.039","volume":"832","author":"T Fujiwaki","year":"2006","unstructured":"Fujiwaki T, Tasaka M, Takahashi N et al. Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 832(1):97\u2013102.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"10","key":"4_CR67","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1093\/jn\/131.10.2748","volume":"131","author":"CC Abnet","year":"2001","unstructured":"Abnet CC, Borkowf CB, Qiao YL et al. A cross-sectional study of human serum sphingolipids, diet and physiologic parameters. J Nutr 2001; 131(10):2748\u20132752.","journal-title":"J Nutr"},{"issue":"9","key":"4_CR68","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1023\/A:1012228000014","volume":"12","author":"CC Abnet","year":"2001","unstructured":"Abnet CC, Borkowf CB, Qiao YL et al. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china. Cancer Causes Control 2001; 12(9):821\u2013828.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"4_CR69","first-page":"CR35","volume":"11","author":"M Gorska","year":"2005","unstructured":"Gorska M, Dobrzyn A, Baranowski M. Concentrations of sphingosine and sphinganine in plasma of patients with type 2 diabetes. Med Sci Monit 2005; 11(1):CR35\u2013CR38.","journal-title":"Med Sci Monit"},{"issue":"2","key":"4_CR70","first-page":"165","volume":"44","author":"S Ribar","year":"2003","unstructured":"Ribar S, Mesaric M, Sedic M. Sphingoid bases as possible diagnostic parameters. Croat Med J 2003; 44(2):165\u2013170.","journal-title":"Croat Med J"},{"issue":"11","key":"4_CR71","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1194\/jlr.D300025-JLR200","volume":"44","author":"B Lieser","year":"2003","unstructured":"Lieser B, Liebisch G, Drobnik W et al. Quantification of sphingosine and sphinganine from crude lipid extracts by HPLC electrospray ionization tandem mass spectrometry. J Lipid Res 2003; 44(11):2209\u20132216.","journal-title":"J Lipid Res"},{"issue":"2","key":"4_CR72","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1194\/jlr.C400011-JLR200","volume":"46","author":"A Schlitt","year":"2005","unstructured":"Schlitt A, Hojjati MR, von Gizycki H et al. Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles. J Lipid Res 2005; 46(2): 196\u2013200.","journal-title":"J Lipid Res"},{"issue":"12","key":"4_CR73","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","volume":"20","author":"XC Jiang","year":"2000","unstructured":"Jiang XC, Paultre F, Pearson TA et al. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 2000; 20(12):2614\u20132618.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"4_CR74","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/aje\/kwj140","volume":"163","author":"JC Nelson","year":"2006","unstructured":"Nelson JC, Jiang XC, Tabas I et al. Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am J Epidemiol 2006; 163(10):903\u2013912.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"4_CR75","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2005.12.029","volume":"189","author":"TS Park","year":"2006","unstructured":"Park TS, Panek RL, Rekhter MD et al. Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice. Atherosclerosis 2006; 189(2):264\u2013272.","journal-title":"Atherosclerosis"},{"issue":"11","key":"4_CR76","doi-asserted-by":"publisher","first-page":"10284","DOI":"10.1074\/jbc.M412348200","volume":"280","author":"MR Hojjati","year":"2005","unstructured":"Hojjati MR, Li Z, Zhou H et al. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in ApoE-deficient mice. J Biol Chem 2005; 280(11):10284\u201310289.","journal-title":"J Biol Chem"},{"issue":"6","key":"4_CR77","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1194\/jlr.M600040-JLR200","volume":"47","author":"J Dong","year":"2006","unstructured":"Dong J, Liu J, Lou B et al. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice. J Lipid Res 2006; 47(6):1307\u20131314.","journal-title":"J Lipid Res"},{"issue":"4","key":"4_CR78","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1194\/jlr.M200401-JLR200","volume":"44","author":"W Drobnik","year":"2003","unstructured":"Drobnik W, Liebisch G, Audebert FX et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res 2003; 44(4):754\u2013761.","journal-title":"J Lipid Res"},{"issue":"3","key":"4_CR79","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11883-010-0100-0","volume":"12","author":"A Kontush","year":"2010","unstructured":"Kontush A, Chapman MJ. Lipidomics as a tool for the study of lipoprotein metabolism. Curr Atheroscler Rep 2010; 12(3):194\u2013201.","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"4_CR80","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jprot.2009.05.006","volume":"72","author":"M Schittmayer","year":"2009","unstructured":"Schittmayer M, Birner-Gruenberger R. Functional proteomics in lipid research: lipases, lipid droplets and lipoproteins. J Proteomics 2009; 72(6):1006\u20131018.","journal-title":"J Proteomics"},{"issue":"1","key":"4_CR81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1586\/14789450.5.1.91","volume":"5","author":"T Alonzi","year":"2008","unstructured":"Alonzi T, Mancone C, Amicone L et al. Elucidation of lipoprotein particles structure by proteomic analysis. Expert Rev Proteomics 2008; 5(1):91\u2013104.","journal-title":"Expert Rev Proteomics"}],"container-title":["Advances in Experimental Medicine and Biology","Sphingolipids and Metabolic Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-0650-1_4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T06:23:32Z","timestamp":1638599012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-0650-1_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9781461406495","9781461406501"],"references-count":81,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-0650-1_4","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}